Metabolites as Prognostic Markers for Metastatic Non-Small Cell Lung Cancer (NSCLC) Patients Treated with First-Line Platinum-Doublet Chemotherapy

Metabolites as Prognostic Markers for Metastatic Non-Small Cell Lung Cancer (NSCLC) Patients Treated with First-Line Platinum-Doublet Chemotherapy

The metabolic requirements of metastatic non-small cell lung (mNSCLC) tumors from patients receiving first-line platinum-doublet chemotherapy are hypothesized to imprint a blood signature suitable for survival prediction. Pre-treatment samples prospectively collected at baseline from a randomized ph...

Full description

Bibliographic Details
Main Authors: Desirée Hao, Arjun Sengupta, Keyue Ding, ER Ubeydullah, Saikumari Krishnaiah, Natasha B. Leighl, Frances A. Shepherd, Lesley Seymour, Aalim Weljie
Format: Article
Language:English
Published: MDPI AG 2020-07-01
Series:Cancers
Subjects:
non-small-cell-lung cancer
metabolomics
lipidomics
NMR
UPLC-MS
overall survival
Online Access:https://www.mdpi.com/2072-6694/12/7/1926

Internet

https://www.mdpi.com/2072-6694/12/7/1926

Similar Items